22 December 2014 | News | By Bureau Report
Bangalore-based Indian Multinational Health Science Company, Sami Labs which manufactures and markets Phytonutrients and standardised herbal extracts, specialty fine chemicals, and organic intermediates used in the nutritional, pharmaceutical and food industries, announced the acquisition of second manufacturing unit in Hyderabad. With the addition of this ultra-modern manufacturing facility, an ISO certified facility situated at SP Biotech Park Genome Valley in Hyderabad, Sami will have overall seven manufacturing units across the globe.
This acquisition will help Sami Labs gain another foothold in the growing biotech market and will aim to strengthen its product portfolio for world markets. The new facility is spread across five acres in Genome Valley with ultra-modern technology and world-class quality stringency. Besides, it is poised to lead product innovation for the pharmaceutical segment.
“We have been diligently working towards increasing our supply chain as we have been witnessing an increased level of acceptance for our line of products in the Indian market. With this new addition we are expecting our output tonnage capacity to go up by 60 to 75 tonnes per day. The next step is to add new products to our kitty of existing ones which will allow us to accelerate new products to market ensuring quality standards” said Dr Muhammed Majeed, Founder and Managing Director, Sami Labs.